Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.

Education & Training

  • Fellowship, 2011
    Children's National Medical Center
  • Fellowship, Medical Biochemical Genetics, 2010
    NIH
  • Residency, 2007
    Royal Victoria Hospital-Montreal
  • MD, 2002
    McGill University

Board Certifications

  • American Board of Medical Genetics/Biochemical
  • American Board of Medical Genetics & Genomics

National Provider ID: 1255623815

Biography

Nicholas Ah Mew, M.D., is director of the Inherited Metabolic Disorders Program at Children’s National Hospital and is associate professor of Pediatrics at The George Washington University. He is a clinical geneticist and clinical biochemical geneticist whose primary research interests include urea cycle disorders, organic acidemias, and other disorders of ammonia metabolism. He is the principal investigator or co-PI of several projects funded through the National Institutes of Health and Patient-Centered Outcomes Research Institute. Dr. Ah Mew is the Children’s National site-PI and an active member of the NIH-funded Urea Cycle Disorders Consortium (UCDC). He has authored multiple publications and book chapters on hyperammonemia and urea cycle disorders and has lectured internationally on these topics.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  •  Medscape
  •  Hyperion Therapeutics 


Research & Publications

Ncarbamylglutamate augments ureagenesis and reduces ammonia and glutamine levels in patients with propionic acidemia

(0001) Pediatrics